Search

Your search keyword '"Lombardi, Rosa"' showing total 1,018 results

Search Constraints

Start Over You searched for: Author "Lombardi, Rosa" Remove constraint Author: "Lombardi, Rosa"
1,018 results on '"Lombardi, Rosa"'

Search Results

1. L’introduzione del Naturalismo in Cina, il ruolo di Mao Dun e il dibattito sulla stampa

5. Non-Financial Reporting in the European Union: Current Issues and Prospects

6. Gender Contribution to the Agenda 2030

7. Portal hypertension-like pattern in coronavirus disease 2019 acute respiratory distress syndrome

10. Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors

11. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

13. Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades

15. Non-financial Information About Intangibles and CSR in the Context of Mandated Non-financial Disclosure: A Configurational Approach for Italian Listed Companies

17. The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic

30. Policy Recommendations for Promoting Touristic Attractivity from Local Government Perspective in Innovative Environments

31. FRI-294 Identification of key predictors of significant weight loss in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: a multicentre study

32. FRI-215-YI MASL-B registry: results from a european cohort of patients with chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease

33. FRI-290 Evaluation of ChatGPT as a counselling tool for Italian-speaking MASLD patients: assessment of accuracy, completeness and comprehensiveness

34. FRI-248-YI The impact of baseline sarcopenia, over time, on liver and cardiovascular damage in patients with metabolic-dysfunction associated steatotic liver disease (MASLD): a prospective study

35. FRI-207-YI Sarcopenia in metabolic-dysfunction associated steatotic liver disease (MASLD): unraveling its role in cardiovascular damage

36. FRI-226 The impact of light to moderate alcohol consumption on liver and cardiovascular damage in metabolic-dysfunction associated steatotic liver disease

40. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

41. Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP)

43. Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes

Catalog

Books, media, physical & digital resources